Valuation: Cogstate Limited

Market Cap 593M 414M 370M 344M 313M 591M 40.07B 4.14B 1.62B 20.43B 1.55B 1.52B 65.56B P/E 2027 *
27.3x
P/E 2028 * 21.9x
Enterprise Value 529M 369M 330M 307M 279M 527M 35.74B 3.69B 1.45B 18.22B 1.39B 1.36B 58.47B EV / Sales 2027 *
4.95x
EV / Sales 2028 * 4.17x
Free-Float
56.43%
Yield 2027 *
1.44%
Yield 2028 * 1.7%
1 day+1.17%
1 week+4.86%
Current month+1.17%
1 month+11.29%
3 months+19.79%
6 months+54.71%
Current year+52.65%
1 week 3.23
Extreme 3.23
3.47
1 month 2.96
Extreme 2.96
3.5
Current year 2.01
Extreme 2.01
3.5
1 year 1.75
Extreme 1.75
3.5
3 years 0.8
Extreme 0.795
3.5
5 years 0.8
Extreme 0.795
3.5
10 years 0.16
Extreme 0.155
3.5
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/12/1999
Chief Executive Officer - 01/12/2005
Director of Finance/CFO - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/03/2011
Chairman 67 03/11/2009
Director/Board Member - 20/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
5/20/26 A Buy

Director

3,600 0.0021%
5/20/26 A Buy

Director

430 0.0003%
4/15/26 A
Myer & Myer Pty Ltd.
SellCompany 9,974,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
+1.17%+4.86%+47.44%+139.58% 414M
-2.59%-5.70%+39.83%+82.45% 70.61B
+3.23%-10.67%+4.87%+55.97% 51.01B
+1.56%+1.17%+5.15%+33.38% 48.1B
+0.39%+0.65%+28.02%+30.24% 42.78B
+0.87%-8.17%+298.53%+645.03% 40.67B
+1.24%-1.01%+5.56%+105.14% 40.3B
-2.13%-1.64%+7.51%+50.31% 30.59B
-0.46%-1.28%+31.47%+19.93% 28.16B
+5.32%+0.06%-7.20%-11.30% 24.36B
Average +0.86%-1.90%+46.12%+115.08% 37.7B
Weighted average by Cap. +0.56%-2.94%+47.30%+116.53%

Financials

2027 *2028 *
Net sales 107M 74.64M 66.66M 62.01M 56.4M 106M 7.22B 746M 292M 3.68B 280M 274M 11.82B 123M 85.52M 76.38M 71.05M 64.63M 122M 8.28B 855M 335M 4.22B 321M 314M 13.54B
Net income 21.73M 15.16M 13.54M 12.6M 11.46M 21.64M 1.47B 152M 59.41M 748M 56.94M 55.7M 2.4B 26.88M 18.76M 16.75M 15.59M 14.18M 26.77M 1.82B 188M 73.5M 926M 70.45M 68.91M 2.97B
Net Debt -64.24M -44.83M -40.04M -37.24M -33.88M -63.96M -4.34B -448M -176M -2.21B -168M -165M -7.1B -81.78M -57.07M -50.97M -47.41M -43.13M -81.43M -5.52B -571M -224M -2.82B -214M -210M -9.04B
Projected Income Statement - Annual - Cogstate Limited
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
09/10/26 A$3.450 +1.17% 165,049
08/10/26 A$3.410 +0.59% 193,266
07/10/26 A$3.390 +2.42% 112,884
06/10/26 A$3.310 -0.90% 167,932
05/10/26 A$3.340 +1.52% 124,587
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Cogstate Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.450AUD
Average target price
4.312AUD
Spread / Average Target
+25.00%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cogstate Limited